Abstract:Objective: Urinary N-acetyl-β-glucosaminidase(NAGase) and Retinal-binding protein(RBP) has been applied as sensitive clinical markers of acute tubulointerstial damage s. Further study is in need to evaluate their relevance with pathological change s and clinical functional changes in different entities of tubulointerstitial di sorders and glomerular diseases. In this study, we explored the relevance of the se markers with the tubulointerstitial lesion and glomerular function in classic al tubulointerstitial disorders as chronic aristolochic acid nephropathy (CAAN) and Sjogren syndrome related nephropathy (SSN), and in glomerulonephropathy as I gA nephropathy (IgAN) and lupus nephropathy (LN). Methodology:This study included 9 patients with SSN, 14 patients with CAAN, 169 patients wit h IgAN and 83 patients with type-Ⅳ or type-Ⅴ LN. All patients were hospitali zed for evaluation, and underwent a renal biopsy. Urinary RBP and NAGase were de termined with ELISA and colourimetric assay respectively. Other laboratory tests including urinary C3, urinary α 2M, 24 hour urinary protein excetion, and ser um creatinine (SCr) were studied. Histological changes of renal biopsy slides we re reviewed and graded semi-quantitatively according to the extent of tubulointe rstitial lesion. Changes of urinary RBP and NAG and their relationship with tubu lar interstitial damage were analyzed, with respect to the four different groups of patients. Influencing factors on urinary RBP and NAG were explored. Results:In patients with Sjogren's disease, CAAN, IgAN and LN, the percentages of patien ts with increased urine RBP and NAG were 100% and 88.89%、85.71% and 71.43 %、37.28% and 56.21%,69.88% and 97.59%, respectively. RBP and NAG excr etion increased while tubular-interstitial lesion deteriorate. In SSN and CAAN, The urinary excretion of RBP and NAG had no significant co-relationship with th at of urinary C3 and α 2M (P0.05). There is no significant change of uri nary RBP and NAG when SCr increase (P0.05). In IgAN, The excretion of RBP had significant co-relationship with that of urinary C3(P0.01), the exc retion of NAG had significant co-relationship with that of urinary C3 and α 2 M(P0.01). RBP and NAG excretion increased while 24h urine protein excret ion or SCr raised. In LN, The excretion of RBP and NAG had significant co-relat ionship with that of urinary C3 and α 2M respectively(P0.01). The excr etion of NAG increased when 24h urine protein aggrandized(P0.05)and that of RBP increased along with SCr. Conclusion:Examinations of urine RBP and NAG are effective methods for assessing renal tubu lar interstitial lesion. Urine RBP and NAG levels correlate with tubular interst itial historical change and show various characters in different nephropathies. In patients characterized by tubulointerstitial lesion, such as SSN and CAAN, ur inary RBP and urinary NAG correlated well with the extent of tubulointerstitial changes. In patients characterized by glomerular lesion and accompanied tubuloin terstitial changes, the extent of using RBP and urinary NAG are influenced by fa ctors including 24-hour urinary protein excretion, urinary protein selectivity, and serum levels of creatinine.

Clinical Application of the Determination of Cystatin C and Urinary Malb for Early Renal Damage of Essential Hypertension

Value of urinary C-terminal agrin fragment in monitoring the progression of early kidney injury in type 2 diabetic patients

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

The Role of Urinary Micro-Albumin and Serum Cystatin C in Early Diagnosis in Pregnancy-Induced Hypertension Patients with Renal Injury

[Early Impairment of Renal Function in Chronic Heart Failure and Its Clinical Significance].

Clinical Value of Urinary Kidney Biomarkers for Estimation of Renal Impairment in Elderly Chinese with Essential Hypertension

Study on the Clinical Significance of Serum Cystatin C in Different Stage of Renal Impairment in Type 2 Diabetic Patients

Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis

Correlation analysis of blood uric acid and urine microalbumin with serum cystatin C in patients with hypertension

Urinary Proteome Analysis by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry with Magnetic Beads for Identifying the Pathologic Presentation of Clinical Early Iga Nephropathy

Clinical applications of the uromicroprotein in early renal injuries

Clinical correlation between Cystatin C and cardiac remodeling in hypertension and coronary heart disease

Analysis risk factors of Cystatin C in hypertension patients

Study of the Relation Between Blood Pressure Parameters and Urine Microprotein in Essential Hypertension Subjects

The diagnostic value of nuclide renal dynamic imaging in early renaldamage in elderly essential hyperten-sion

Detecting Serous Levels of Cystatin C and Exploring its Role in the Evaluation of Glomerular Filtration Function

The clinical significance of detection of the level of blood HbA1c,urine mAlband β2MG in the early renal damage of DM

In Reply to 'serum Cystatin C May Diagnose Rather Than Predict Acute Kidney Injury'

Comparison of renal dynamic imaging and contrast-enhanced ultrasound in assessing early renal damage in patients with hypertension

Changes of Urinary L-FABP, KIM-1, NGAL and Serum Cystatin C in Diabetic Nephropathy and Its Clinical Value

Clinical Application of the Urinary Markers of Renal Tubular Injury